{"id":"https://openalex.org/W2165864070","doi":"https://doi.org/10.1158/1535-7163.mct-14-0669","title":"Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2","display_name":"Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2","alternate_titles":[],"publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W2165864070","doi":"https://doi.org/10.1158/1535-7163.mct-14-0669","mag":"2165864070","pmid":"https://pubmed.ncbi.nlm.nih.gov/25673820","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4394038"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-14-0669","doi":"https://doi.org/10.1158/1535-7163.mct-14-0669","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-14-0669","pdf_url":"https://mct.aacrjournals.org/content/molcanther/14/4/1014.full.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2165864070"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://mct.aacrjournals.org/content/molcanther/14/4/1014.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054848065","display_name":"Heloisa Prado Soares","orcid":"https://orcid.org/0000-0002-5185-2583","observed_orcids":["https://orcid.org/0000-0002-5185-2583"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Heloisa P. Soares","raw_affiliation_strings":["1Division of Hematology-Oncology, David Geffen School of Medicine, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology-Oncology, David Geffen School of Medicine, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063872681","display_name":"Ming Ming","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ming Ming","raw_affiliation_strings":["2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050560508","display_name":"Michelle Mellon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michelle Mellon","raw_affiliation_strings":["2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025012222","display_name":"Steven H. Young","orcid":"https://orcid.org/0000-0002-6407-7870","observed_orcids":["https://orcid.org/0000-0002-6407-7870"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven H. Young","raw_affiliation_strings":["2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California","3CURE: Digestive Diseases Research Center, University of California at Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California","institution_ids":[]},{"raw_affiliation_string":"3CURE: Digestive Diseases Research Center, University of California at Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082838869","display_name":"Liang Han","orcid":"https://orcid.org/0000-0003-3578-2914","observed_orcids":["https://orcid.org/0000-0003-3578-2914"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Liang Han","raw_affiliation_strings":["2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112905348","display_name":"James Sinnet-Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James Sinnet-Smith","raw_affiliation_strings":["2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California","3CURE: Digestive Diseases Research Center, University of California at Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California","institution_ids":[]},{"raw_affiliation_string":"3CURE: Digestive Diseases Research Center, University of California at Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077935609","display_name":"Enrique Rozengurt","orcid":"https://orcid.org/0000-0002-7838-9170","observed_orcids":["https://orcid.org/0000-0002-7838-9170"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Enrique Rozengurt","raw_affiliation_strings":["2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California","3CURE: Digestive Diseases Research Center, University of California at Los Angeles, Los Angeles, California","4Molecular Biology Institute, University of California at Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California","institution_ids":[]},{"raw_affiliation_string":"3CURE: Digestive Diseases Research Center, University of California at Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"4Molecular Biology Institute, University of California at Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5077935609"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":4.5859,"has_fulltext":true,"cited_by_count":116,"citation_normalized_percentile":{"value":0.96483844,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"14","issue":"4","first_page":"1014","last_page":"1023"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3k-mtor-inhibitors","display_name":"PI3K/mTOR inhibitors","score":0.8709999918937683},{"id":"https://openalex.org/keywords/bez235","display_name":"BEZ235","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mtorc2","display_name":"mTORC2","score":0.8240000009536743},{"id":"https://openalex.org/keywords/mek-erk-signaling","display_name":"MEK/ERK signaling","score":0.9169999957084656},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/negative-feedback-loop","display_name":"negative feedback loop","score":0.6800000071525574},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6679999828338623},{"id":"https://openalex.org/keywords/rictor","display_name":"Rictor","score":0.7860000133514404},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8859999775886536},{"id":"https://openalex.org/keywords/4e-bp1","display_name":"4E-BP1","score":0.8370000123977661},{"id":"https://openalex.org/keywords/ribosomal-protein-s6-kinase","display_name":"S6K","score":0.8270000219345093},{"id":"https://openalex.org/keywords/pi3k-independent-signaling","display_name":"PI3K-independent signaling","score":0.7649999856948853},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6769999861717224},{"id":"https://openalex.org/keywords/pd0325901","display_name":"PD0325901","score":0.9380000233650208}],"concepts":[{"id":"https://openalex.org/C107846503","wikidata":"https://www.wikidata.org/wiki/Q14876061","display_name":"mTORC2","level":5,"score":0.9109306335449219},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.9039171934127808},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.8664417266845703},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.7037976384162903},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6952469348907471},{"id":"https://openalex.org/C104202773","wikidata":"https://www.wikidata.org/wiki/Q18031289","display_name":"P70-S6 Kinase 1","level":4,"score":0.6742277145385742},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.6096750497817993},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5510344505310059},{"id":"https://openalex.org/C43060935","wikidata":"https://www.wikidata.org/wiki/Q18043110","display_name":"RPTOR","level":4,"score":0.5476736426353455},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5092872381210327},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.46741628646850586},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4504309296607971},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3997059464454651},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.31006181240081787}],"mesh":[{"descriptor_ui":"D000076225","descriptor_name":"Mechanistic Target of Rapamycin Complex 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000076226","descriptor_name":"Rapamycin-Insensitive Companion of mTOR Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011972","descriptor_name":"Receptor, Insulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017451","descriptor_name":"Receptors, Somatomedin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017526","descriptor_name":"Receptor, IGF Type 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046912","descriptor_name":"Multiprotein Complexes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055785","descriptor_name":"Gene Knockdown Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-14-0669","doi":"https://doi.org/10.1158/1535-7163.mct-14-0669","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-14-0669","pdf_url":"https://mct.aacrjournals.org/content/molcanther/14/4/1014.full.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:25673820","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25673820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4394038","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4394038/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-14-0669","doi":"https://doi.org/10.1158/1535-7163.mct-14-0669","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-14-0669","pdf_url":"https://mct.aacrjournals.org/content/molcanther/14/4/1014.full.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1832016924","display_name":"PKD1 Signaling and Crosstalk Mechanisms in Intestinal Epithelial Cell Regulation","funder_award_id":"R01DK100405","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G4738137833","display_name":"Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma","funder_award_id":"P01CA163200","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6009717147","display_name":"CURE: Digestive Diseases Research Center","funder_award_id":"P30DK041301","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G6513000328","display_name":null,"funder_award_id":"I01 BX001473","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"}],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2165864070.pdf","grobid_xml":"https://content.openalex.org/works/W2165864070.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1519191891","https://openalex.org/W1523693806","https://openalex.org/W1565276921","https://openalex.org/W1971727526","https://openalex.org/W1977534471","https://openalex.org/W1989657978","https://openalex.org/W2010601523","https://openalex.org/W2014096417","https://openalex.org/W2015151766","https://openalex.org/W2015512041","https://openalex.org/W2029376990","https://openalex.org/W2031531665","https://openalex.org/W2033589713","https://openalex.org/W2038141559","https://openalex.org/W2041098455","https://openalex.org/W2046822015","https://openalex.org/W2047401805","https://openalex.org/W2053086998","https://openalex.org/W2054024439","https://openalex.org/W2067019627","https://openalex.org/W2080245613","https://openalex.org/W2081690486","https://openalex.org/W2086262311","https://openalex.org/W2086281394","https://openalex.org/W2095984220","https://openalex.org/W2097773105","https://openalex.org/W2105299865","https://openalex.org/W2106201632","https://openalex.org/W2108541764","https://openalex.org/W2112463549","https://openalex.org/W2119018696","https://openalex.org/W2126430769","https://openalex.org/W2126783165","https://openalex.org/W2129202918","https://openalex.org/W2129433069","https://openalex.org/W2132834292","https://openalex.org/W2133934356","https://openalex.org/W2140306297","https://openalex.org/W2150174916","https://openalex.org/W2153607816","https://openalex.org/W2155228605","https://openalex.org/W2157949003","https://openalex.org/W2157983986","https://openalex.org/W2158170204","https://openalex.org/W2158305336","https://openalex.org/W2158683414","https://openalex.org/W2159664830","https://openalex.org/W2163515898","https://openalex.org/W2166539171","https://openalex.org/W2168992025","https://openalex.org/W6683300772","https://openalex.org/W6684308109"],"related_works":["https://openalex.org/W2565517177","https://openalex.org/W868919483","https://openalex.org/W2008984728","https://openalex.org/W1989420273","https://openalex.org/W7099621102","https://openalex.org/W2156258785","https://openalex.org/W1121084917","https://openalex.org/W2028351423","https://openalex.org/W2029376990","https://openalex.org/W2066831622"],"abstract_inverted_index":{"The":[0,129,141],"PI3K/AKT/mTOR":[1],"pathway,":[2],"which":[3],"is":[4],"aberrantly":[5],"stimulated":[6],"in":[7,90,101,167,240],"many":[8],"cancer":[9,242],"cells,":[10],"has":[11],"emerged":[12],"as":[13],"a":[14,91,102,148,176,197,225],"target":[15],"for":[16],"therapy.":[17],"However,":[18],"mTORC1/S6K":[19,69],"also":[20],"mediates":[21],"negative":[22,227],"feedback":[23,32,228],"loops":[24,33],"that":[25,49,156,172,182,189,220],"attenuate":[26],"upstream":[27],"signaling.":[28],"Suppression":[29],"of":[30,38,51,112,114,143,152,180,199,202,206,213],"these":[31],"opposes":[34],"the":[35,61,98,210],"growth-suppressive":[36],"effects":[37],"mTOR":[39],"inhibitors":[40,131,223],"and":[41,84,116,127,145],"leads":[42],"to":[43,235],"drug":[44],"resistance.":[45],"Here,":[46],"we":[47],"demonstrate":[48],"treatment":[50],"PANC-1":[52],"or":[53,133],"MiaPaCa-2":[54],"pancreatic":[55,241],"ductal":[56],"adenocarcinoma":[57],"(PDAC)":[58],"cells":[59,170],"with":[60,109,187],"dual":[62,221],"PI3K/mTOR":[63,222],"kinase":[64],"inhibitor":[65,160],"(PI3K/TOR-KI)":[66],"BEZ235":[67,95,144,214],"blocked":[68],"activation":[70,185],"(scored":[71],"by":[72,79,122,139,158,231],"S6":[73],"phosphorylation":[74,81,87,113,193],"at":[75,82,88],"Ser(240/244)),":[76],"mTORC1/4E-BP1":[77],"(assayed":[78],"4E-BP1":[80],"Thr(37/46)),":[83],"mTORC2-mediated":[85,191],"AKT":[86,115,192],"Ser(473),":[89,195],"concentration-dependent":[92],"manner.":[93,104],"Strikingly,":[94],"markedly":[96,208],"enhanced":[97,183,236],"MEK/ERK":[99,184,237],"pathway":[100,238],"dose-dependent":[103],"Maximal":[105],"ERK":[106,118,136,216],"overactivation":[107,119,137],"coincided":[108,186],"complete":[110],"inhibition":[111,151],"4E-BP1.":[117],"was":[120],"induced":[121,138],"other":[123],"PI3K/TOR-KIs,":[124],"including":[125],"PKI-587":[126],"GDC-0980.":[128],"MEK":[130],"U126":[132],"PD0325901":[134,146],"prevented":[135],"PI3K/TOR-KIs.":[140],"combination":[142],"caused":[147],"more":[149],"pronounced":[150],"cell":[153],"growth":[154],"than":[155],"produced":[157],"each":[159],"individually.":[161],"Mechanistic":[162],"studies":[163],"assessing":[164],"PI3K":[165],"activity":[166,239],"single":[168],"PDAC":[169],"indicate":[171],"PI3K/TOR-KIs":[173,181],"act":[174],"through":[175],"PI3K-independent":[177],"pathway.":[178],"Doses":[179],"those":[188],"inhibited":[190],"on":[194,215],"suggesting":[196],"role":[198],"mTORC2.":[200],"Knockdown":[201],"RICTOR":[203],"via":[204],"transfection":[205],"siRNA":[207],"attenuated":[209],"enhancing":[211],"effect":[212],"phosphorylation.":[217],"We":[218],"propose":[219],"suppress":[224],"novel":[226],"loop":[229],"mediated":[230],"mTORC2,":[232],"thereby":[233],"leading":[234],"cells.":[243]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2165864070","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
